Calretinin, CD34, and αsmooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary

Modern Pathology

Volumn 19, Issue 3, 2006, Pages 364-372

  Lee, Eung Seok ^a,e   Leong, Anthony S Y ^b   Kim, Young Sik ^a   Lee, Ju Han ^a   Kim, Insun ^c   Geung, Hwan Ahn ^d   Hye, Sun Kim ^d   Yi, Kyeong Chun ^d  

^a Korea University   (South Korea)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Korea University College of Medicine   (South Korea)

^d Sungkyunkwan University   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

Immunohistochemistry; Invasive implants; Ovarian serous borderline tumors

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALRETININ; CD34 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL LOSS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; CYTOPATHOLOGY; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIAGNOSTIC ACCURACY; FEMALE; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; MYOFIBROBLAST; OVARY TUMOR; PERITONEUM METASTASIS; PRIORITY JOURNAL; STROMA CELL;

ACTINS; ADULT; AGED; ANTIGENS, CD34; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CHI-SQUARE DISTRIBUTION; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PERITONEUM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33244473680     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800539     Document Type: Article

References (19)

1. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
2. Serov SF, Scully RE, Sobin LH. Histological Typing of Ovarian Tumors: WHO International Histological Classification of Tumors, no. 9. Springer: Heidelberg, 1973.
3. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors: histologic features and prognosis. Cancer 1988;62:2212-2222.
4. Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111-1128.
5. Bell DA, Longacre TA, Prat J, et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives. Hum Pathol 2004;35:934-948.
6. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol 2001;25:419-432.
7. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539-557.
8. Doglioni C, Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-1046.
9. Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. Pathol Res Pract 1996;192:137-147.
10. + fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 2002;441:564-568.
11. Suster S, Fisher C. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997;21:195-200.
12. Nakayama H, Enzan H, Miyazaki E, et al. CD34 positive stromal cells in gastric adenocarcinomas. J Clin Pathol 2001;54:846-848.
13. Khalifa MA, Montgomery EA, Ismiil N, et al. What are CD34+ cells in benign peripheral nerve sheath tumors? Am J Clin Pathol 2000;114:123-126.
14. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319-1330.
15. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397-409.
16. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20:1331-1345.
17. Silva EG, Kurman RJ, Russell P, et al. Symposium: ovarian tumors of borderline malignancy. Int J Gynecol Pathol 1996;15:281-302.
18. Silverberg SG, Bell DA, Kurman RJ, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004;35:910-917.
19. Sherman ME, Berman J, Birrer MJ, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 2004;35:918-933.